BiotechTube
Home/Waypoint Bio/Xinchen Wang, Ph.D.
XW

Xinchen Wang, Ph.D.

Co-founder & CEO

Waypoint Bio

Therapeutic Areas

Oncology

Waypoint Bio Pipeline

DrugIndicationPhase
CLDN18.2 CAR-TGastric, GE junction & Pancreatic cancerLead Optimization
Undisclosed CAR-TLung & Prostate cancerIn Vivo Discovery

Leadership Team at Waypoint Bio

DP
David Phizicky, Ph.D.
Co-founder & CSO
PK
Patrick Kaifosh
Chief Technology Officer
View full Waypoint Bio profile